Irritable bowel syndrome (IBS) is linked to an increased long-term risk of developing inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD). A large study using UK Biobank data followed 447,631 participants for over 14 years and found that individuals with IBS had a significantly higher chance of developing IBD.
Irritable bowel syndrome (IBS) is linked to an increased long-term risk of developing inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD). A large study using UK Biobank data followed 447,631 participants for over 14 years and found that individuals with IBS had a significantly higher chance of developing IBD. Specifically, IBS patients had a 68% higher risk of any IBD, with a 60% increased risk for UC and a 104% higher risk for CD. This elevated risk persisted even after 10 years.
The study also analyzed 76,992 participants through a digestive health questionnaire and found that IBS patients had a higher prevalence of IBD. Among IBS subtypes, diarrhea-predominant IBS (IBS-D) showed the strongest link to IBD, with a 3.72 times higher likelihood of having IBD, suggesting a closer connection between IBS-D and inflammatory conditions.
These findings suggest that IBS and IBD may share overlapping mechanisms. Clinically, IBS patients, especially those with persistent symptoms or IBS-D, should be monitored closely for signs of IBD. Early detection and treatment of inflammatory changes could improve outcomes and provide better disease management for these patients.
Introduction: Anal squamous cell carcinoma is an increasingly common but largely preventable cancer. Most cases arise from persistent high-risk human papillomavirus (HPV) infection, progressing through high-grade squamous intraepithelial lesions (HSIL). This comprehensive review summarizes the...
Introduction: Acute infectious gastroenteritis can trigger persistent gastrointestinal symptoms long after the infection has resolved, leading to post-infection disorders of gut-brain interaction (PI-DGBI). This global Rome Foundation study evaluated the prevalence, risk factors, and clinical...
Introduction: Gut microbiota alterations have been implicated in the pathogenesis of irritable bowel syndrome (IBS), making fecal microbiota transplantation (FMT) a promising therapeutic strategy. However, clinical trials have reported conflicting results. This updated meta-analysis evaluated...
Introduction: Laparoscopic adhesiolysis offers several short-term advantages over open surgery for adhesive small bowel obstruction (ASBO). However, its long-term impact on recurrence, quality of life, and incisional hernia remains uncertain. The LASSO trial provides the...
Introduction: Growing evidence suggests that Parkinson's disease (PD) may originate in the gut, with pathological α-synuclein spreading to the brain through the vagus nerve. This study investigated whether sitagliptin, a widely used DPP-4 inhibitor for...
Introduction: Necrotizing enterocolitis (NEC) is one of the most serious gastrointestinal emergencies in neonates. Early identification of infants requiring surgical intervention is critical but remains challenging. This study compared bedside abdominal ultrasonography (US) with abdominal...
We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.